Drug Shortage Report for HALOPERIDOL INJECTION, USP

Last updated on 2018-08-10
Report ID 50916
Drug Identification Number 02406411
Brand name HALOPERIDOL INJECTION, USP
Common or Proper name HALOPERIDOL
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) HALOPERIDOL
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 1mL MD Vial
ATC code N05AD
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-05-28
Actual start date
Estimated end date
Actual end date 2018-08-02
Shortage status Resolved
Updated date 2018-08-10
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information